Japan Animal Referral Medical Center Co., Ltd. (6039) AI Stock Analysis

0 Followers

Japan Animal Referral Medical Center Co., Ltd.

(TSE/TYO:6039)

Select Model

Rating:71Outperform

Price Target:JPY 1,034.00▲(8.96% Upside)

Action:upgraded

Date:08/21/26

Strong financial performance with robust revenue and profit growth is the primary driver. Mixed technical indicators and reasonable valuation support the overall score.

Positive Factors

Sustained revenue growthRevenue has more than doubled across the period and continued growing at a double-digit rate in FY2026. This indicates expanding demand for the company’s specialized referral-care services and provides a durable base for future operating leverage and reinvestment.

Negative Factors

Sharp free-cash-flow deteriorationThe sharp move into negative free cash flow indicates that operating cash is currently being absorbed by reinvestment or working-capital needs. Repeated historical volatility makes cash conversion less predictable, potentially limiting internally funded expansion and increasing reliance on financing.

Japan Animal Referral Medical Center Co., Ltd. (6039) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 11.15B
Dividend Yield: 1.26%
Average Volume (3M): 59.94K
Price to Earnings (P/E): 12.7
Beta (1Y): 0.85
Revenue Growth: 15.68%
EPS Growth: 49.24%
Country: Japan
Employees: 328
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Personal Products & Services

Japan Animal Referral Medical Center Co., Ltd. Business Overview & Revenue Model

Company Description

Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized de...

Japan Animal Referral Medical Center Co., Ltd. Financial Statement Overview

Summary

Strong revenue growth accelerating to 30% and doubled net income, supported by solid balance sheet expansion and improved leverage, though volatile free cash flow from heavy investments.

Income Statement

85Very Positive

Balance Sheet

80Positive

Cash Flow

70Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	6.36B	6.19B	5.28B	4.27B	3.87B	2.98B
Gross Profit	2.65B	2.51B	1.81B	1.43B	1.41B	1.07B
EBITDA	1.81B	1.74B	1.29B	961.39M	996.73M	680.27M
Net Income	892.85M	833.43M	520.98M	337.22M	380.66M	286.94M
Balance Sheet
Total Assets	11.24B	11.31B	8.75B	8.77B	8.58B	7.11B
Cash, Cash Equivalents and Short-Term Investments	1.25B	1.59B	1.11B	1.34B	1.92B	1.07B
Total Debt	5.16B	5.16B	3.48B	3.86B	3.98B	3.92B
Total Liabilities	6.28B	6.43B	4.61B	4.96B	4.87B	4.60B
Stockholders Equity	4.96B	4.88B	4.15B	3.81B	3.71B	2.51B
Cash Flow
Free Cash Flow	0	-953.45M	418.70M	-141.26M	82.62M	-44.14M
Operating Cash Flow	0	1.40B	1.37B	899.78M	810.92M	557.57M
Investing Cash Flow	0	-2.49B	-994.38M	-985.86M	-784.07M	-1.43B
Financing Cash Flow	0	1.58B	-608.03M	-392.32M	820.59M	722.09M

Japan Animal Referral Medical Center Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price949.00

Price Trends

50DMA1006.44Negative

100DMA1021.34Negative

200DMA1144.12Negative

Market Momentum

MACD-15.06Positive

RSI30.47Neutral

STOCH17.66Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6039, the sentiment is Negative. The current price of 949.00 is below the 20-day moving average (MA) of 989.95, below the 50-day MA of 1006.44, and below the 200-day MA of 1144.12, indicating a bearish trend. The MACD of -15.06 indicates Positive momentum. The RSI at 30.47 is Neutral, neither overbought nor oversold. The STOCH value of 17.66 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6039.

Japan Animal Referral Medical Center Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

JP:6039 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:6039	71Outperform	JPY 13.42B	12.72	―	1.26%	15.68%	49.24%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
JP:9628	58Neutral	JPY 25.28B	7.49	―	5.09%	―	―

* Consumer Cyclical Sector Average

Performance Comparison

JP:6039 and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	JP:6039	Japan Animal Referral Medical Center Co., Ltd.	949.00	42.01	4.63%
	JP:9628	San Holdings, Inc. (Japan)	1119.00	-293.28	-20.77%

Japan Animal Referral Medical Center Co., Ltd. Corporate Events

JARMeC Delivers Double-Digit Profit Growth and Plans Higher Dividend

Aug 14, 2026

Japan Animal Referral Medical Center reported strong results for the three months ended June 30, 2026, with net sales up 11.6% year on year to ¥1,644 million and operating profit surging 35.0% to ¥349 million. Profit attributable to owners...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 21, 2026

Japan Animal Referral Medical Center Co., Ltd. AI Stock Analysis